Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.70% is 79% below its 5-year average of 3.37%, near the low end of its 5-year range (0.00%–109.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 67.88% below its 12-month average of 2.18%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.70%.
DEBT TO ASSETS RATIO
0.70%
DEBT TO ASSETS RATIO AVG TTM
2.18%
DEBT TO ASSETS RATIO AVG 3Y
3.68%
DEBT TO ASSETS RATIO AVG 5Y
3.37%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-67.88%
CURRENT VS 3Y AVG
-80.98%
CURRENT VS 5Y AVG
-79.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
+438.01%
vs the sector median at left
Bluejay Diagnostics, Inc.
Market Cap
$787624.00
Debt to Assets Ratio
0.70%
TTM Avg
2.18%
3Y Avg
3.68%
5Y Avg
3.37%
Market Cap
$878396.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885939.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$888387.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.36M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | $787624.00 | 0.70% | 2.18% | 3.68% | 3.37% |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 0.38% | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | 0.00% | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.01% | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 0.00% | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 0.00% | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 0.11% | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.01% | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | 0.38% | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61819.00 | 2.89% | N/A | N/A | N/A |
Debt/Assets
0.7%
Debt/Equity
0.01
Current Ratio
4.64
Interest Coverage
-8287.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.70% |
| 2026-03-31 | 1.80% |
| 2025-12-31 | 1.69% |
| 2025-09-30 | 2.92% |
| 2025-06-30 | 3.78% |
| 2025-03-31 | 3.55% |
| 2024-12-31 | 3.34% |
| 2024-09-30 | 2.89% |
| 2024-06-30 | 3.93% |
| 2024-03-31 | 6.24% |
| 2023-12-31 | 7.25% |
| 2023-09-30 | 4.71% |
| 2023-06-30 | 5.00% |
| 2023-03-31 | 4.21% |
| 2022-12-31 | 3.64% |
| 2022-09-30 | 2.27% |
| 2022-06-30 | 4.76% |
| 2022-03-31 | 1.41% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 109.71% |
| 2021-06-30 | 80.05% |
| 2020-12-31 | 69.59% |
